JT
Insider buying
John T. Treace bought $247K of Treace Medical Concepts, Inc. (TMCI) stock
John T. Treace, Chief Executive Officer, 10% of Treace Medical Concepts, Inc. (TMCI), bought 55,944 shares of TMCI stock worth $247K, per an SEC Form 4 filed Aug 24, 2026.
It was an open-market purchase.
The trade happened on Aug 20, 2026, 4 days before it was made public.
TMCI has moved +0.4% since the trade date, from $4.46 to $4.48 (Sep 21, 2026 close).
- Traded
- Aug 20, 2026
- Disclosed
- Aug 24, 2026
- Filing delay
- 4 days
- Price since
- +0.4%
- Role
- Chief Executive Officer, 10%
- Source
- SEC Form 4
More TMCI insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.